Historical record - last NADAC effective date: 8/23/2023

Product Information

ANASTROZOLE 1 MG TABLET is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.1631 per EA under NDC 69117000301. Its NADAC has been published 185 times since Feb 12, 2020.

FDA first approved this application on Nov 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ANASTROZOLE 1 MG TABLET

Anastrozole Tablets
$0.1631per EA

Strength

1 mg/1

NDC

69117000301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/23/2023

Active Ingredients

ANASTROZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA206037

FDA Approved

11/9/2018

TE Code

AB

On Market Since

2/28/2019

Pharmacological Classes

Aromatase Inhibitor
Aromatase Inhibitors

Price Statistics

The NADAC for ANASTROZOLE 1 MG TABLET has been published 185 times since Feb 12, 2020, and over the history we have for it it has risen 15.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1631 per EA
All-time high$0.1631 (Aug 23, 2023)
All-time low$0.1041 (Jul 20, 2022)
Median price$0.1329
Average price$0.1291
Largest weekly change+23.8% (Jul 19, 2023)
Weeks tracked185
Tracking sinceFeb 12, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+7.7%

5Y

+22.3%

All

+15.8%

Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 14%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ANASTROZOLE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ANASTROZOLE 1 MG TABLET, manufactured by Yiling Pharmaceutical Inc., is $0.1631 per EA (NDC 69117000301), effective Aug 23, 2023.

How has the price of ANASTROZOLE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ANASTROZOLE 1 MG TABLET has risen 15.8%. It has been tracked across 185 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for ANASTROZOLE 1 MG TABLET?

Since Feb 12, 2020, the NADAC for ANASTROZOLE 1 MG TABLET has ranged from a low of $0.1041 (Jul 20, 2022) to a high of $0.1631 (Aug 23, 2023), with a median of $0.1329 per EA.

Are there cheaper alternatives to ANASTROZOLE 1 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANASTROZOLE 1 MG TABLET, is $0.1401 per EA — about 14% below ANASTROZOLE 1 MG TABLET.

Who manufactures ANASTROZOLE 1 MG TABLET?

ANASTROZOLE 1 MG TABLET (NDC 69117000301) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.